Leonteq Securities AG’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-377
Closed -$1.01K 1365
2022
Q4
$1.01K Hold
377
﹤0.01% 1218
2022
Q3
$1.08K Hold
377
﹤0.01% 1210
2022
Q2
$1.87K Hold
377
﹤0.01% 1205
2022
Q1
$2.68K Hold
377
﹤0.01% 1189
2021
Q4
$6.85K Hold
377
﹤0.01% 1177
2021
Q3
$7.37K Sell
377
-1,000
-73% -$38K ﹤0.01% 1064
2021
Q2
$61.7K Buy
1,377
+1,000
+265% +$46.4K ﹤0.01% 805
2021
Q1
$18.9K Sell
377
-500
-57% -$34.1K ﹤0.01% 892
2020
Q4
$78.4K Buy
+877
New +$73.8K ﹤0.01% 718

Other funds holding CELL

Leonteq Securities AG's CELL Position: Q1 2023 in Review

Leonteq Securities AG sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 377 shares — an estimated $1.01K sold.

Leonteq Securities AG first reported a position in CELL in Q4 2020 and held it in 9 quarters. The position peaked at $78.4K in Q4 2020. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Leonteq Securities AG reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 377 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $1.01K.
  • Leonteq Securities AG first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Leonteq Securities AG's PhenomeX Inc. Common Stock position peaked at $78.4K in Q4 2020.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Leonteq Securities AG's 13F filing for Q1 2023, filed 11 Mar 2026.